C1AG
ELV icon

Client 1st Advisory Group’s Elevance Health ELV Stock Holding History

Client 1st Advisory Group’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$432K Buy
1,117
+36
+3% +$13.4K 0.11% 87
2026
Q1 		$316K Sell
1,081
-64
-6% -$21K 0.1% 96
2025
Q4 		$401K Sell
1,145
-31
-3% -$10.5K 0.13% 84
2025
Q3 		$380K Buy
1,176
+330
+39% +$103K 0.13% 82
2025
Q2 		$329K Hold
846
– – 0.12% 90
2025
Q1 		$368K Hold
846
– – 0.14% 78
2024
Q4 		$312K Sell
846
-4
-0.5% -$1.67K 0.12% 93
2024
Q3 		$442K Sell
850
-112
-12% -$59.8K 0.18% 69
2024
Q2 		$521K Buy
962
+79
+9% +$41.8K 0.22% 55
2024
Q1 		$458K Buy
883
+127
+17% +$63.2K 0.21% 60
2023
Q4 		$356K Buy
756
+136
+22% +$62.9K 0.17% 68
2023
Q3 		$270K Hold
620
– – 0.14% 83
2023
Q2 		$275K Sell
620
-278
-31% -$128K 0.15% 81
2023
Q1 		$413K Hold
898
– – 0.22% 58
2022
Q4 		$461K Sell
898
-5
-0.6% -$2.54K 0.27% 50
2022
Q3 		$410K Buy
903
+112
+14% +$53.6K 0.25% 47
2022
Q2 		$382K Buy
791
+25
+3% +$12.4K 0.23% 49
2022
Q1 		$376K Buy
766
+272
+55% +$124K 0.18% 60
2021
Q4 		$229K Buy
+494
New +$208K 0.11% 71

Other funds holding ELV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MIHAS
Maj Invest Holding A/S Copenhagen K, Denmark $2.2B AUM 25.64% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

Client 1st Advisory Group's ELV Position: Q2 2026 in Review

Client 1st Advisory Group increased its Elevance Health (ELV) stake by 3.3% in Q2 2026, buying an estimated $13.4K and bringing the position to 1,117 shares worth $432K. The position accounts for 0.11% of the portfolio, ranked #87.

Client 1st Advisory Group first reported a position in ELV in Q4 2021 and has held it in 19 quarters since. The position peaked at $521K in Q2 2024. 278 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Client 1st Advisory Group held 1,117 shares of Elevance Health worth $432K as of Q2 2026.
  • Client 1st Advisory Group bought 36 Elevance Health shares in Q2 2026, an estimated $13.4K.
  • Elevance Health made up 0.11% of Client 1st Advisory Group's portfolio in Q2 2026, its #87 holding.
  • Client 1st Advisory Group first reported a position in Elevance Health in Q4 2021 and has held it in 19 quarters since.
  • Client 1st Advisory Group's Elevance Health position peaked at $521K in Q2 2024.
  • 278 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Client 1st Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.